- Home
- SANG vs BDTX Comparison
SANG vs BDTX Comparison
Compare SANG & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- BDTX
- Stock Information
- Founded
- SANG 1984
- BDTX 2014
- Country
- SANG Canada
- BDTX United States
- Employees
- SANG N/A
- BDTX N/A
- Industry
- SANG Computer Software: Programming Data Processing
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SANG Technology
- BDTX Health Care
- Exchange
- SANG Nasdaq
- BDTX Nasdaq
- Market Cap
- SANG 193.2M
- BDTX 161.6M
- IPO Year
- SANG 2021
- BDTX 2020
- Fundamental
- Price
- SANG $6.25
- BDTX $2.62
- Analyst Decision
- SANG
- BDTX Strong Buy
- Analyst Count
- SANG 0
- BDTX 4
- Target Price
- SANG N/A
- BDTX $15.50
- AVG Volume (30 Days)
- SANG 8.8K
- BDTX 591.8K
- Earning Date
- SANG 11-06-2024
- BDTX 11-05-2024
- Dividend Yield
- SANG N/A
- BDTX N/A
- EPS Growth
- SANG N/A
- BDTX N/A
- EPS
- SANG N/A
- BDTX N/A
- Revenue
- SANG $244,406,000.00
- BDTX N/A
- Revenue This Year
- SANG $4.18
- BDTX N/A
- Revenue Next Year
- SANG $7.26
- BDTX N/A
- P/E Ratio
- SANG N/A
- BDTX N/A
- Revenue Growth
- SANG N/A
- BDTX N/A
- 52 Week Low
- SANG $2.33
- BDTX $2.09
- 52 Week High
- SANG $6.75
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- SANG 56.57
- BDTX 31.71
- Support Level
- SANG $6.18
- BDTX $3.16
- Resistance Level
- SANG $6.75
- BDTX $3.44
- Average True Range (ATR)
- SANG 0.24
- BDTX 0.22
- MACD
- SANG 0.00
- BDTX 0.03
- Stochastic Oscillator
- SANG 38.27
- BDTX 0.61
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.